Culture Biosciences and Google Cloud Announce Collaboration to Revolutionize Bioprocess Development
September 10, 2024 10:00 ET
|
Culture Biosciences
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences—a leader in automated bioprocess development, optimization and data science —announces a strategic...
Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
September 13, 2023 06:53 ET
|
Culture Biosciences
South San Francisco, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences, a leading provider of innovative, future-forward bioprocessing solutions, is pleased to announce the appointment of Darcy...
Biotech and Biopharma Executive Eliana Clark Joins Culture Biosciences’ Advisory Board
July 19, 2023 06:39 ET
|
Culture Biosciences
SAN FRANCISCO, July 19, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences is excited to welcome Eliana Clark, PhD, Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc., to...
Biotech Executive Beth Thompson-Webb Joins Culture Biosciences’ Board of Directors
July 13, 2023 06:33 ET
|
Culture Biosciences
BOSTON, July 13, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences has appointed Beth Thompson-Webb, Chief Commercial Officer at Virica Biotech, as Independent Director to the company’s Board of...
Culture Biosciences and Cytiva team up to innovate in upstream bioprocessing to advance the development and manufacturing of new therapies
June 15, 2023 07:00 ET
|
Culture Biosciences
BOSTON, June 15, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences and Cytiva are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and...
Culture Biosciences Establishes Advisory Board of Biotech and Biopharma Executives to Guide the Corporate Strategy and Accelerate Growth
June 01, 2023 08:31 ET
|
Culture Biosciences
SAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences today announced the formation of its inaugural Advisory Board. The group of seasoned biotech and biopharma executives will...